Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls

Launched by UNIVERSITY OF WYOMING · Dec 3, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a mobile phone app designed to help improve healthy eating habits, specifically by increasing the intake of fruits and vegetables among adolescent girls aged 14 to 18. The study will look at whether using this app can lead to better eating scores, lower body weight, and healthier blood sugar levels over the course of one year. Participants will use the app twice a week and their progress will be compared to a group using a different app focused on fun food facts.

To participate, girls must be biologically female and between the ages of 15 and 18. However, those with certain medical conditions, like diabetes or other serious health issues, will not be eligible. If you or someone you know fits these criteria and is interested in improving their diet, this study could be a great opportunity! Participants will gain insights into healthy eating while contributing to important research on dietary habits in young women.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Biologically female
• • Female gender
• • Between the ages of 15y and 18y
• Exclusion Criteria:
• • Biologically male
• • Self-identify as male
• • BMI percentile (for age and sex) \< 5th%
• * Diagnosis from a medical profession of any of the following conditions, syndromes, diseases that may affect growth, glucose metabolism, blood clotting, cognitive development\*:
• • Any form of or history of cancer
• • Any form of diabetes (type I, II, insipidus)
• • Precocious puberty
• • Crohn's disease
• • Congenital heart defect
• • Cystic fibrosis
• • Cerebral palsy
• • Anorexia nervosa
• • Bulimia nervosa
• • Active infection
• • Fever
• • Hemophilia
• • Hydrocephalus
• • intestinal atresia
• • Jeune syndrome
• • Klippel-Trénaunay syndrome
• • Legg-Calvé-Perthes
• • Long QT syndrome
• • Muenke syndrome
• • Myelomeningocele
• • Necrotizing Enterocolitis
• • Neutropenia
• • Non-alcholoic fatty liver diease
• • Pfeiffer Syndrome
• • Saethre-Chotzen syndrome
• • Shwachman-Diamond syndrome
• • Spinal muscular atrophy
• • Sturge-Weber syndrome
• • Ulcerative Colitis
• • von Willebrand disease
• • Pancreatitis
• • Hurler syndrome
• • Niemann-Pick disease
• • Tay-Sachs disease
• • Gaucher disease
• • Krabbe disease
• • Zellweger syndrome
• • Wilson disease
• • Brachial Plexus Palsy
• • Brain Abscess or Spinal Abscess
• • Coarctation of the Aorta
• • Aortic stenosis
• • Ventricular septal defect
• • Patent ductus arteriosus or mitral valve abnormalities
• • Congenital Adrenal Hyperplasia
• • Craniofacial Microsomia
• • Duchenne Muscular Dystrophy
• • Dyskeratosis Congenita
• • Galactosemia
• • Maple syrup urine disease
• • Phenylketonuria
• • Turner syndrome
• • Prader-Wili disease
• • History of polycystic ovary syndrome
• • History of thyroid disease (either hyper or hypo)
• • History of adrenal disease (including Cushing's syndrome, Addison's disease)
• • Use of medications related to metabolism/weight such as insulin, corticosteroids, growth hormone, sulfonylurea, thiazolidinediones, beta blockers, calcium channel blockers, bupropion, reboxetine, molindone, clozapine, olanzapine, topiramate, zonisamide, valproate, carbamazepine, lithium, hypolipidemic drugs, highly-active antiretroviral therapies